2 reports

  • 8. MARKET FORECAST

ONE STEP FORWARD IN THIS DIRECTION WAS THE FIRST HUMAN TRIAL OF AN ANTI-BCMA CAR-T THERAPY.

  • Motor Vehicle
  • Targeted Therapy
  • Therapy
  • Amgen Inc.
  • Celgene Corporation
  • THERAPIES

CAR-T IS ONE AMONGST A NUMBER OF ADVANCED NOVEL PERSONALIZED IMMUNOTHERAPIES.

  • Lymphoma
  • Monoclonal Antibody
  • Motor Vehicle
  • Therapy
  • Amgen Inc.